Log In
person
Organogenesis Holdings Inc
ORGO
summarize
1 total product line
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Regenerative Medicine |
Biologically-Derived Tissue Scaffolding Products; private insurance
These companies manufacture tissue scaffolding products, primarily from placental tissue (such as amniotic membrane allografts) and sell directly to their customers. These are used for skin wound healing and dermal reconstruction. Their products are paid for primarily through private health insurance.
|
433.14M | 100.00% |
| keyboard_arrow_down |
Regenerative Medicine
Biologically-Derived Tissue Scaffolding Products; private insurance
|
433.14M | 100.00% |
| keyboard_arrow_right |
These companies manufacture tissue scaffolding products, primarily from placental tissue (such as amniotic membrane allografts) and sell directly to their customers. These are used for skin wound healing and dermal reconstruction. Their products are paid for primarily through private health insurance.
|
||